Targets › ENOS
1 program from 1 company in 1 trial: 1 Phase 1; Ophthalmology; next expected readout Jul 2027.
Open in Phaseline: the race on ENOS, likelihood bands and readouts
| Company | Drug | Targets | Highest phase | Conditions | Next expected readout |
|---|---|---|---|---|---|
| National Aeronautics and Space Administration (NASA) | Vitamin B-Complex Supplement One-carbon pathway optimizer; supplies methylated B vitamins (5-methyltetrahydrofolate, ri | MTHFR, SHM1, MTHFD1, ENOS | Phase 1 | Optic Disc Edema | Jul 2027 |
Optic Disc Edema (1)
small molecule (1)
National Aeronautics and Space Administration (NASA) (1)
Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.